Germany – Pharmaceutical products – Arzneimittel-Rabattverträge ab 01.10.2026 zu diversen Wirkstoffen im Rahmen eines Open-House-Verfahrens

The subject of this publication is the award of contracts in accordance with Section 130a, paragraph 8, SGB V for various active substances within the framework of a so-called Open-House procedure: On the basis of uniform contractual conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or communities of pharmaceutical companies are offered the opportunity to conclude rebate contracts in accordance with Section 130a, paragraph 8, SGB V. The earliest commencement of the contract is 01.10.2026. The maximum contract duration is 24 months from this date.